Transition your compounds seamlessly into the clinic with a program analysis focused on risk-mitigation and evaluations of progress. As a TD2 client, you’ll get a comprehensive plan outlining the best path toward first-in-man phase I clinical trials—all based on our experts’ deep experience and calculated and careful assessments of your project. This includes:

  • Safety package/plan, including toxicology, pharmacokinetics and pharmacology
  • Chemistry, Manufacturing and Controls (CMC), including bioanalytical methods, drug formulation, manufacturing and stability
  • A full regulatory package
  • Clinical trial designs with your approval path(s) in mind, including well-characterized patient populations, safety, feasibility of proposed dose, route of administration, inclusion/exclusion criteria, incorporation of appropriate biomarkers and any other special program requirements

With this plan in place, our drug development project managers facilitate the entire program from the pre-investigational new drug (IND) stage through clinical development. By having one project team responsible for program navigation from preclinical into clinical development, you’ll enjoy a seamless transition at every juncture of your drug’s journey.

Ask us how you can get your clinical plan started today.

Need help with your model selection? Contact TD2 to get more information about our murine models available for immediate use.

Contact Us Now
You may also be interested in
Clinical Technology and Next-Generation Oncology Trials Read the Post Clinical The Clinical Trial Process Continues Amid COVID-19 Read the Post Clinical The Trends Behind Successful Cancer Treatments Read the Post